Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

As presented in Table 1, the proportion of male patients was marginally lower in the TB group than that in the non-TB group (49.4% vs. 58.5%), whereas vitamin D deficiency was more prevalent among children with TB (36.0% vs. 16.0%).

Source: Baseline characteristics and infection profiles of the study population. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Age-dependent immune heterogeneity and the limited diagnostic utility of peripheral blood biomarkers in pediatric tuberculosis: a real-world cohort study with multidimensional model evaluation

Source: Article title.

This retrospective observational study enrolled 280 children aged 0 to 18 years (186 TB cases, 94 non-TB controls) admitted between January 2024 and December 2025.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Age-dependent immune heterogeneity and the limited diagnostic utility of peripheral blood biomarkers in pediatric tuberculosis: a real-world cohort study with multidimensional model evaluation

Cohort study · Frontiers in Immunology · 2026

Original publication title

Age-dependent immune heterogeneity and the limited diagnostic utility of peripheral blood biomarkers in pediatric tuberculosis: a real-world cohort study with multidimensional model evaluation

Aifeng Liu; Jun Deng; Hongmei Chen; Xiaohua Ma

Copyright © 2026 Liu, Deng, Chen and Ma.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Age is the key variable associated with pediatric TB and demonstrates marked age-dependent immune-inflammatory heterogeneity. Peripheral blood immune biomarkers added modest diagnostic information beyond age alone, with statistically significant yet clinically modest improvements. The incremental value of CD8+ T cell count was most evident in intermediate-risk decision scenarios (threshold probabilities 0.40 to 0.78) and in adolescents ≥12 years, rather than as a universal screening tool. MP co-infection was not associated with significant alterations in TB-related immune-inflammatory profiles in this cohort. These findings emphasize age stratification as a core principle in pediatric TB evaluation and suggest caution regarding over-reliance on routine lymphocyte subset testing for diagnostic purposes, particularly in younger children where clinical and radiological assessment remains paramount.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To investigate age-dependent heterogeneity in immune-inflammatory profiles among children with tuberculosis (TB) and to evaluate the additive diagnostic value of peripheral blood biomarkers beyond age alone, while assessing the impact of Mycoplasma pneumoniae co-infection on TB-related immune parameters.

Source: Objective

Abstract: What methods does the paper describe?

This retrospective observational study enrolled 280 children aged 0 to 18 years (186 TB cases, 94 non-TB controls) admitted between January 2024 and December 2025. Peripheral lymphocyte subsets, routine blood parameters, and systemic inflammatory indices (NLR, PLR, SII, MLR, SIRI) were compared between groups. Logistic regression identified independent correlates. ROC analysis, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate model performance. Age-stratified analysis (three strata: <5, 5 to 12, ≥12 years) was performed using ANCOVA with age as a covariate.

Age × Group interaction analyses and 1:1 age-matched sensitivity analyses were conducted to formally test effect modification and exclude age confounding. Sensitivity analyses comparing bacteriologically confirmed versus clinically diagnosed cases and MP-only controls versus TB-MP co-infected cases were also performed.

Source: Methods

Abstract: Results

Age was the sole variable independently associated with pediatric TB (adjusted OR = 1.118, 95% CI: 1.046 to 1.194, P = 0.001). TB patients exhibited significantly lower CD8+ T cell, NK cell, and lymphocyte counts and higher PLR compared with controls, but these differences were highly age-dependent. Age-stratified analysis revealed striking heterogeneity: immune-inflammatory differences were highly significant in adolescents ≥12 years (CD8+ T cells and NK cells: adjusted P < 0.009 and P < 0.008, respectively) but virtually absent in children <5 years (all P > 0.05).

Formal Age × Group interaction analyses confirmed significant interactions for CD8+ T cells (P < 0.001, partial η2 = 0.089), NK cells (P < 0.001, partial η2 = 0.196), and lymphocyte count (P < 0.001, partial η2 = 0.404). Age-matched sensitivity analysis further confirmed that CD8+ T cell and NK cell differences in the ≥12 years stratum remained significant after matching (CD8+ T: P = 0.004; NK: P < 0.001), whereas CD4+ T cell differences were abolished (P = 0.113).

The age-only model produced an AUC of 0.686 (95% CI: 0.618 to 0.755). The age + CD8+ T cell combined model showed statistically significant improvement (AUC difference = 0.041, 95% CI: 0.010 to 0.071; DeLong P = 0.009; likelihood-ratio test P < 0.001), with good calibration (Hosmer: Lemeshow P = 0.228; Brier score = 0.187; McFadden R2 = 0.127), positive net benefit across threshold probabilities of approximately 0.40 to 0.78 in DCA, and significant reclassification improvement (continuous NRI = 0.505, 95% CI: 0.258 to 0.755, P < 0.001; IDI = 0.038, 95% CI: 0.011 to 0.068, P = 0.003; event NRI+ = 0.419).

None of the other age-combined models (age + NLR, SII, PLR, or MP) showed significant improvement over age alone (all DeLong P > 0.05). Within the TB cohort, MP co-infection was not observed to significantly alter immune-inflammatory profiles after age adjustment (all P > 0.05, partial η2 < 0.01). Sensitivity analyses confirmed immunological consistency between bacteriologically confirmed and clinically diagnosed cases (all P > 0.05, partial η2 ≤ 0.017).

Source: Results

Abstract: Conclusion

Age is the key variable associated with pediatric TB and demonstrates marked age-dependent immune-inflammatory heterogeneity. Peripheral blood immune biomarkers added modest diagnostic information beyond age alone, with statistically significant yet clinically modest improvements. The incremental value of CD8+ T cell count was most evident in intermediate-risk decision scenarios (threshold probabilities 0.40 to 0.78) and in adolescents ≥12 years, rather than as a universal screening tool. MP co-infection was not associated with significant alterations in TB-related immune-inflammatory profiles in this cohort. These findings emphasize age stratification as a core principle in pediatric TB evaluation and suggest caution regarding over-reliance on routine lymphocyte subset testing for diagnostic purposes, particularly in younger children where clinical and radiological assessment remains paramount.

Source: Conclusion
Authors’ abstract

Background

Pediatric tuberculosis (TB) remains a diagnostic challenge due to atypical presentations and low pathogen detection rates. Overlapping clinical features with Mycoplasma pneumoniae (MP) infection further complicate differential diagnosis. Immune-inflammatory parameters are age-dependent, yet how age modifies these profiles in children with TB and MP co-infection remains poorly understood.

Objective

To investigate age-dependent heterogeneity in immune-inflammatory profiles among children with tuberculosis (TB) and to evaluate the additive diagnostic value of peripheral blood biomarkers beyond age alone, while assessing the impact of Mycoplasma pneumoniae co-infection on TB-related immune parameters.

Methods

This retrospective observational study enrolled 280 children aged 0 to 18 years (186 TB cases, 94 non-TB controls) admitted between January 2024 and December 2025. Peripheral lymphocyte subsets, routine blood parameters, and systemic inflammatory indices (NLR, PLR, SII, MLR, SIRI) were compared between groups. Logistic regression identified independent correlates. ROC analysis, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate model performance. Age-stratified analysis (three strata: <5, 5 to 12, ≥12 years) was performed using ANCOVA with age as a covariate.

Age × Group interaction analyses and 1:1 age-matched sensitivity analyses were conducted to formally test effect modification and exclude age confounding. Sensitivity analyses comparing bacteriologically confirmed versus clinically diagnosed cases and MP-only controls versus TB-MP co-infected cases were also performed.

Results

Age was the sole variable independently associated with pediatric TB (adjusted OR = 1.118, 95% CI: 1.046 to 1.194, P = 0.001). TB patients exhibited significantly lower CD8+ T cell, NK cell, and lymphocyte counts and higher PLR compared with controls, but these differences were highly age-dependent. Age-stratified analysis revealed striking heterogeneity: immune-inflammatory differences were highly significant in adolescents ≥12 years (CD8+ T cells and NK cells: adjusted P < 0.009 and P < 0.008, respectively) but virtually absent in children <5 years (all P > 0.05).

Formal Age × Group interaction analyses confirmed significant interactions for CD8+ T cells (P < 0.001, partial η2 = 0.089), NK cells (P < 0.001, partial η2 = 0.196), and lymphocyte count (P < 0.001, partial η2 = 0.404). Age-matched sensitivity analysis further confirmed that CD8+ T cell and NK cell differences in the ≥12 years stratum remained significant after matching (CD8+ T: P = 0.004; NK: P < 0.001), whereas CD4+ T cell differences were abolished (P = 0.113).

The age-only model produced an AUC of 0.686 (95% CI: 0.618 to 0.755). The age + CD8+ T cell combined model showed statistically significant improvement (AUC difference = 0.041, 95% CI: 0.010 to 0.071; DeLong P = 0.009; likelihood-ratio test P < 0.001), with good calibration (Hosmer: Lemeshow P = 0.228; Brier score = 0.187; McFadden R2 = 0.127), positive net benefit across threshold probabilities of approximately 0.40 to 0.78 in DCA, and significant reclassification improvement (continuous NRI = 0.505, 95% CI: 0.258 to 0.755, P < 0.001; IDI = 0.038, 95% CI: 0.011 to 0.068, P = 0.003; event NRI+ = 0.419).

None of the other age-combined models (age + NLR, SII, PLR, or MP) showed significant improvement over age alone (all DeLong P > 0.05). Within the TB cohort, MP co-infection was not observed to significantly alter immune-inflammatory profiles after age adjustment (all P > 0.05, partial η2 < 0.01). Sensitivity analyses confirmed immunological consistency between bacteriologically confirmed and clinically diagnosed cases (all P > 0.05, partial η2 ≤ 0.017).

Conclusion

Age is the key variable associated with pediatric TB and demonstrates marked age-dependent immune-inflammatory heterogeneity. Peripheral blood immune biomarkers added modest diagnostic information beyond age alone, with statistically significant yet clinically modest improvements. The incremental value of CD8+ T cell count was most evident in intermediate-risk decision scenarios (threshold probabilities 0.40 to 0.78) and in adolescents ≥12 years, rather than as a universal screening tool. MP co-infection was not associated with significant alterations in TB-related immune-inflammatory profiles in this cohort. These findings emphasize age stratification as a core principle in pediatric TB evaluation and suggest caution regarding over-reliance on routine lymphocyte subset testing for diagnostic purposes, particularly in younger children where clinical and radiological assessment remains paramount.

Publication and source details

Original title: Age-dependent immune heterogeneity and the limited diagnostic utility of peripheral blood biomarkers in pediatric tuberculosis: a real-world cohort study with multidimensional model evaluation

Aifeng Liu; Jun Deng; Hongmei Chen; Xiaohua Ma

Frontiers in Immunology · 2026

* Correspondence: Xiaohua Ma, 2018050711@usc.edu.cn

†These authors have contributed equally to this work and share first authorship

Copyright © 2026 Liu, Deng, Chen and Ma.2026Liu, Deng, Chen and Mahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by grants from The Science and Technology Program of Hunan Province (NO. 2025JJ80543, NO. 2026JJ82010) and the Scientific Research Project of Hunan Provincial Health Commission (NO. 20254080).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:34:07.443379+00:00

DOI: 10.3389/fimmu.2026.1954622 · PMC13682975